(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.
Korro Bio's earnings in 2025 is -$87,411,000.On average, 7 Wall Street analysts forecast KRRO's earnings for 2025 to be -$90,846,437, with the lowest KRRO earnings forecast at -$109,868,756, and the highest KRRO earnings forecast at -$80,476,516. On average, 7 Wall Street analysts forecast KRRO's earnings for 2026 to be -$78,316,703, with the lowest KRRO earnings forecast at -$118,883,629, and the highest KRRO earnings forecast at -$57,375,906.
In 2027, KRRO is forecast to generate -$100,971,265 in earnings, with the lowest earnings forecast at -$126,396,022 and the highest earnings forecast at -$64,137,060.